Stryker reports third quarter 2026 operating results

Portage, Michigan, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2026:

GlobeNewsWire • an hour ago

SYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds?

SYK's Q3 earnings may reflect strong hospital equipment demand and cybersecurity recovery, but supply constraints, vascular disruptions and margin pressures remain.

Zacks Investment Research • Oct 28, 2026

Stryker to participate in the 2026 Jefferies Global Healthcare Conference

Portage, Michigan, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Jefferies Global Healthcare Conference on Tuesday, November 17, 2026, at the Waldorf Hilton and ME Hotel in London. Spencer Stiles, President, Chief Operating Officer, Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will also participate in a fireside chat session at 8:30 a.m.

GlobeNewsWire • Oct 27, 2026

Stryker completes acquisition of ZuriMED to enhance its shoulder offering

Portage, Michigan, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced it has completed the acquisition of ZuriMED, a privately held company and developer of the FiberLocker® System.

GlobeNewsWire • Oct 26, 2026

Countdown to Stryker (SYK) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Get a deeper insight into the potential performance of Stryker (SYK) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks Investment Research • Oct 26, 2026

It's Too Soon To Upgrade Stryker Corporation

Stryker Corporation remains a global leader in medical technologies, with strong segment breadth and robust product innovation. SYK delivered solid financial growth in H1 2026, with revenue up 6.1% and EBITDA rising to $3.45 billion. Management projects 2026 organic revenue growth of 8.3–9.3% and adjusted EPS of $14.95–$15.10, supported by demographic tailwinds.

Seeking Alpha • Oct 26, 2026

Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Oct 22, 2026

These 2 dividend stocks are worth owning for a lifetime

A dividend stock earns its place in a long-term portfolio by doing more than mailing shareholders a quarterly check. It needs a business that can fund those payments while investing sufficiently to stay “competitive.

Invezz • Oct 22, 2026

Stryker's Sonopet 3 Secures FDA Clearance to Improve Surgical Accuracy

SYK's Sonopet 3 secures FDA clearance, promising enhanced surgical precision and efficiency, with a full commercial launch expected later this fall.

Zacks Investment Research • Oct 21, 2026

PAHC or SYK: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Oct 21, 2026